Τόμος 2 (1984) – Τεύχος 1 – Άρθρο 4 – Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Ελληνική Έκδοση – Volume 2 (1984) – Issue 1 – Article 4 – Epitheorese Klinikes Farmakologias και Farmakokinetikes-Greek Edition

Nephrotoxicity and Ototoxicity of Newer Aminoglycosides

Gr.N. Tsekos and G.E. Chrysos

Tsekos, G. and Chrysos, G.: Nephrotoxicity and Ototoxicity of Newer Aminoglycosides, Epitheorese Klin. Farmakol. Farmakokinet. 2(1): 42-52 (1984)

Toxicity, Nephrotoxicity, Ototoxicity

2.         Riff, L.J., Jackson, G.G.: Pharmacology of gentamicin in man. J. Infect. Dis. 124 (Suppl): 98 (1971).

3.         Gyselynck, A.M., Forrey, A., Cutler, R.: Pharmacokinetics of gentamicin: distribution and plasma and renal clearance. J. Infect. Dis. 124 (Suppl): 70 (1971).

4.         Fabre, J., Rudhardt, M., Blanchard, P., Regamey, C.: Persistence of sisomicin, gentamicin in renal cortex and medulla compared with other organs and serum of rats. Kidney Intern. 10: 444 (1976).

5.         Wilson, T.W., Mahon, W.A, Inaba, T. et al.; Elimination of tritiated gentamicin in normal human subjects and in patients with severely impaired renal function. Clin. Pharmacol· Ther. 14: 815 (1973).

6.         Gingel, J.C., Chisholm, G.M., Caiman, J.S. et al.: The dose, distribution and excretion of gentamicin with special reference to renal failure. J. Infect. Dis. 119: 396 (1969).

7.         Gary, N.E.: Peritoneal clearance and removal of gentamicin. J. Infect. Dis., 124 (Suppl.): 26 (1971).

8.         Smithinas, T., Hyams, P.J., Matalon, R. et al.: The use of gentamicin in peritoneal dialysis. 1. Pharmacol, results. J. Infect. Dis. 124 (Suppl·): 77 (1971).

9.         Falco, F.G.. Smith, H.M., Arden, G.M.: Nephrotoxicity of the aminoglycosides and gentamicin. J. Infect. Dis., 114: 406 (1969).

10.       Waitz, J.A., Moss, E.L.J., Weinjtein, M.J.: Aspects of the chronic toxicity of gentamicin sulfate in cats. J. Infect. Dis. 124 (Suppl·): 125 (1971).

11.        Houghton, D.C., Hartnett, M.N., Campbell-Boswell, M., Porter, G.A., Bennet, W.M.: A light and electron microscopic analysis of gentamicin nephrotoxicity in rats. Am. J. Pathol., 82: 589 (1976).

12.       Harrison, W.O., Silverblatt, F.T., Turck, M.: Gentamicin nephrotoxicity: failure of cephalospirins to potentiate injury in rats. Antimicrob. Agents Chemother. 8: 209 (1975).

13.       Kosek, J.D., Mazza, R.I., Cousins, M.J.: Nephrotoxicity of gentamicin. Lab. Invest. 30: 48 (1974).

14.       Koenig, H.: Intravital staining of lysosomes by basic dyes and metallic ions. J. Histochem. Cytochem. 11: 120 (1963).

15.       Read W.K., Bay, W.W.: Basic cellular lesion in chloroquine toxicity. Lab. Invest. 24: 246 (1971).

16.       Hsu. C.H., Kurtz, T.V., Elasterling, R.E. et al.: Potentiation of gentamicin nephrotoxicity by metabolic acidosis. Proc. Soc. Exp. Biol. Med. 146: 894 (1974).

17.       Barr, R.S., Wilson, H.E., Nazzaferri, E.L.; Hypomagnesemic hypocalcemia secondary to renal magnesium wasting: a possible consequence of high-dose gentamicin therapy. Ann. Intern. Med. 82: 646 (1975).

18.       Mazze, R.I., Cousins, M.J.: Combined nephrotoxicity of gentamicin and methoxyflurane anaesthesia: a case report. Br. J. Anaesth. 45: 394 (1973).

19.       Bennett, W.M., Hartnett, M.N., Gilbert, D., Houghton, D.C., Porter, G.A.: Effect of sodium intake on gentamicin nephrotoxicity in the rat. Proc. Soc. Exp. Biol. Med., 151: 736 (1976).

20.      Hewitt, W.L.: Gentamicin: toxicity in perspective. Postgrad. Med. J. 50 (Suppl·) 7: 55 (1974).

21.       Haeger Knut: The toxidty of aminoglycosides with special reference to netilmicin. Clin. Trials J. 17, 6: 360 (1980).

22.       Holmes, A.M., Hesling, C.M., Wilson, T.M.: Drug induced secondary hyperaldonism in patients with pulmonary tuberculosis. G. J. Med. 39: 299 (1970).

23.       Cabanilles, F., Burgos, R., Rodriquez, R.C. et al.: Nephrotoxicity of combined cephalothin-gentamicin regimen. Arch. Intern. Med. 135: 85 (1975).

24.       Dellinger, P., Murphy, T., Pinn. V., Barza. M., Weinstein, L.: The protective effect of cephalothin against gentamicin induced nephrotoxicity in rats. Antimicrob. Agents Chemother. 9: 172 (1976).

25.       Luft, F.C., Pater, V., Yum, Μ.Ν., Kleit, S.A.: Nephrotoxicity, of cephalothin-gentamicin combination in rats. Antimicrob. Agents Chemother. 9: 831 (1976).

26.       Fanning, W.L., Jick, H., Gump, D.W.: Rising BUN with gentamicin, cephalothin or both. Program and Abstracts; Fifteen Interscience Conference on Antimicrobial Agents and Chemotherapy, Wasington D.C. September 24-26, Abstract, p. 2402.

27.       Schultze, R.C., Witners, K.E., Kauffman, H.: Possible nephrotoxicity of gentamicin. J. Infect. Dis. 124: 145 (1971).

28.      Kleinknecht, D., Jüngers, P., Fillstre, J.R.: Nephrotoxicity of cephaloridine. Ann. Intern. Med. 80: 421 (1974).

29.       Noone, P., Parsons, T.M.S., Pattison, J.R. et al.: Experience in monitoring gentamicin therapy during treatment of serious gram-negative sepsis. Brit. Med. J. 1: 147 (1974).

30.      Plager, J.E.: Association of renal injury with combined cephalothin-gentamicin therapy among patients severely ill with malignant disease. Cancer 37: 1937 (1976).

31.       Klasterksy, J.: The use of synergistic combinations of antibiotics in patients with hematological diseases. Clin. Hematol. 5: 361 (1976).

32.       Bloomfield, C.D., Kennedy, B.J.: Cephalothin, carbenicillin, and gentamicin combination therapy for febrile patients with acute non-lymphocytic leukemia. Cancer 34: 431 (1974).

33.       Wilfert, J.N., Burke, J.F., Bloomer, H.A., Smith, C.B.: Renal insufficiency associated with gentamicin therapy. J. Infect. Dis. 124: 148 (1971).

34.       McFlenry, M.C., Garvan, R.L., Van Ommen, R.E. et al.: Therapy with gentamicin for bacteremic results with 53 patients. J. infect. Dis., 124 (Suppl.): 164 (1971).

35.       Kahn, T., Stein, P.M.: Gentamicin and renal failure. Lancet 1: 498 (1972).

36.       Gary, N.E., Buzzcoi, Salaki, J. et al.: Gentamicin-associated acute renal failure. Arch. Intern. Med. 136: 1101 (1976).

37.       Bobron, S.N., Jaffe, E., Young, R.C.: Anuria and acute tubular necrosis associated with gentamicin and cephalothin. JAMA 222: 1546 (1972).

38.      Appel, G.B. and Neu, H.C.: The nephrotoxicity of antimicrobial agents. N. Engl. J. Med. 296: 772 (1977).

39.       Wellwood, J.M., Simpson, P.M., Tighe, J.R. et al.: Evidence of gentamicin nephrotoxicity in patients with altografts. Br. Med. J. 3: 278 (1975)

40.      Lockwood, W.R., Sower, U.D.: Tobramycin and gentamicin concentrations in the serum of normal and anephric patients. Antimicrob. Agents Chemother. 31: 125 (1973)

41.       Jaffe, G., Meyers B.R., Hirschman, S.Z.: Pharmacokinetics of tobramycin in patients with stable renal impairment, patients undergoing peritoneal dialysis and patients on chronic hemodialysis. Antimicrob. Agents Chemother. 5: 611 (1974)

42.       Weelws J.S., Emmerson, J.L., Gibson, W.R. et al.: Preclinical toxicology studies with tobramycin. Toxicol. Appl. Pharmacol. 25: 398 (1973)

43.       Szwed, Luft F.C., Black, H.R. et al.: Comparison of the distribution of tobramycin and gentamicin in the body fluid of dogs. Antimicrob. Agents Chemother. 5: 444 (1974)

44.       De Rosa, F., Buoncristiani, U., Gapitanucci, P. et al.: Tobramycin: Toxicological and pharmacological studies in animals and pharmacokinetic research in patients with varying degrees of renal impairment, J. Int. Med. Res. 2: 100 (1974)

45.       Patel, V., Cuft, F., Yum, M.N. et al.: Lysosomal enzyme markers in gentamicin and tobramycin nephrotoxicity. Program and abstracts: 15th Intercience Conference on Antimicrobial Agents and Chemotherapy. Washington. D.D. Sept. 24-26, (1975)

46.       Neu, H.C.: Guidelines to antibiotic therapy in renal failure. Med. Times 101: 47 (1976)

47.       Klasterksy, J., Hengens. C., Debusscher, L.: Empiric therapy for cancer patients: comperative study of ticarcillin-tobramycin, ticarcillin-cephalothin and cephalothin tobramycin, Antimicrob. Agents Chemother. 7: 640 (1975)

48.      Gillett, P., Niser, Melikain, V.,, Falk, R.: Tobramycin-cephalothin nephrotoxicity. Letters to the Editor. Lancet 1: 547 (1976)

49.       Flumpert, G., Fillastre, J.R., Oskenheniery, G. et al.: Pharmacokinetics of amikacin. Presented at the Ninth International Congress on Chemotherapy (1975)

50.       Smith, C.R., Bauchman, K.L., Eduards, C.G., Rogers, J.F. and Lietman, R.S.: Controlled comparison of amikacin and gentamicin. N. Engl. J. Med. 296: 349 (1977)

51.       Feld, R., Valdivieso, Bodey, G.P., Rodriguez, V.; Comparison of amikasin and tobramycin in the treatment of infection in patients with cancer, J. Infect. Dis. 135: 61 (1977)

52.       Black, R.E., Lau, W.K., Weinstein, R.J.; Amikacin – garbenicillin vs. gentamicin-carbenicillin: prospective controlled trial of empiric therapy in leukopenic patients. Program and Abstracts: 15th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, D.C., September 24-26, (1975)

53.       Meyer, R.D.: Diagnosis and treatment-amikacin. Ann. Intern. Med. 95: 328 (1981)

54.       Lerner, A.M., Cone, L.A., Jansen, W., Reyes, M.P., Blair, D.C., Wright, G.E., Lorber, R.R.: Randomised, controlled trial of the comparative efficacy, auditory toxicity, and nephrotoxicity of tobramycin and netilmicin. The Lancet 1: 1123 (1983)

55.       Pechere, J.C., Dugal, R.: Clinical pharmacokinetics of aminoglycoside antibiotics. Clin. Pharmacokinetics 4: 170 (1979)

56.       Humbert G., Fillastre, J.P., Leroy, A., Oksenhendler, G.: Pharmacokinetics of sisomicin in the presence of normal and impaired renal function. Infection 4 (Suppl.): 393 (1976)

57.       Neu, H.C., Appel, G.B., Parry, M.F. et al.: Pharmacokinetics of sisomicin in normal patients and those with depressed renal function. Infection 4 (Suppl.): 403 (1976)

58.       Gruenwaldt, C., Arcieri, G., Gionti, A.: Results of international clinical trials with sisomicin. Infection 7 (Suppl.) 3: 301 (1979)

59.       Robbins, G., Tettenborn, D.: Toxicity of sisomicin in animals. Infection 4 (Suppl. 4): 349 (1976)

60.      Luft, F.C., Block, R., Sloan, R.S., Yum, M.N., Costello, R„ Maxwell, D.R,: Comparative nephrotoxicity of aminoglycoside antibiotics in rats. J. Infect. Dis. 138: 541 (1978)

61.       Brummett, R.E., Fox, K.E., Bendrick, T.W., Himes, D.L.: Ototoxicity of tobramycin, gentamicin, amikacin and sisomicin in the guinea pig, J. Antimicrob. Chemother. 4 (Suppl. A): 73 (1978)

62.       Keating, M.J., Bodey, G.P., Valdivieso, M., Rodriquez, V.:

A randomised comparative trial of three aminoglycosides. Comparison of continuous infusions of gentamicin, amikacin and sisomicin combined with carbenicillin in treatment of infections in neutropenic patients with malignancies. Medicine 58: 159 (1979)

63.       Luft, C.F.: The nephrotoxic potential of netilmicin as determined in a rat model. Scand. J. Infect. Dis. (Suppl.) 23: 82 (1980)

64.       Chiu, P.J.S., Miller, G., Brown, A., Long, J. and Waitz, J.: Renat Pharmacology of netilmicin. Antimicrob. Agents and Chemother 11: 821 (1977)

65.       Chiu, P.J.S., Brown, A,, Miller, G., Lond, G.F.: Renal excretion of gentamicin in anesthetised dogs. Antimicrob. Agents Chemother. 10: 277 (1976)

66.       Regamey, C., Gordon, R.C. and Kirby, W.M.M.: Comparative pharmacokinetics of tobramycin and gentamicin. Clin. Pharmacol. Ther. 14: 396 (1973)

67.       Clarke, J„ Libke, R. and Regamy, C.: Comparative Pharmacokinetics of amikacin and kanamycin. Clin. Pharmacol. Ther. 15: 610 (1974)

68.      Thompson, W.L: Aminoglycoside nephrotoxicity in dogs. Influence of drug and dosage regimen. Scand. J. Infect. Dis. (Suppl.) 23: 91 (1980)

69.       Bowman, R.L., Silverblatt, F.J., Kaloyanides, G.J.: Coparison of the nephrotoxicity of netilmicin and gentamicin in rats. Antimicrob. Agents Chemother. 12: 474 (1977)

70.       Herting R.L., Lane, A.Z., Lorber, R.R., Wright, J.J.; Netilmicin: Chemical development and overview of clinical research. Scand. J. Infect. Dis. (Suppl.) 23: 20 (1960)

71.       Dahlager, J.I.: The effect of netilmicin and other aminoglycosides on renal function. Scand. J. Infect. Dis. (Suppl.) 23: 96 (1980)

72.       Brummett, R.E., Fox, K.E., Brown, R.T., Himes, D.L.: Comparative ototoxic liability of netilmicin and gentamicin. Arch. Otolaryngol. 104: 579 (1978)

73.       Wershall, J.: The ototoxic potential of netilmicin compared with amikacin. Scand. J. Infect. Dis. (Suppl.) 23: 104 (1980)

74.       Herting, R.L., Lorber, R.R.. Miller, M. and Danzig, M.R.: Multicenter comparative evaluation or netilmicin and gentamicin in adult patients. Drug Res. 31 (1), 2: 366 (1981)

75.       Delti, L.C.; Drug dosage in patients with renal failure. Clin. Pharmacol, Ther. 16: 241 (1974)

76.       Kunin, C.M.: Antibiotic usage in patients with renal impairment. Hosp. Pract. 7: 141 (1972)

77.       Whelton, A.: Antibacterial chemotherapy in renal insufficiency: a review. Antibiot. Chemother. 18: 1 (1974)

78.       Van Scoy, R.E., Wilson, W.R.: Antimicrobial agents in patients with renal insufficiency. Mayo Clin. Proc. 52: 246 (1983)

79.       Weinstein, L.: Antimicrobial agents: streptomycin, gentamicin and other aminoglycosides. In: The pharmacological basis of therapeutics. Fifth edition. Edited by S. Goodman, A. Gilman. MacMillan Publishing Company, pp. 1167, New York (1975)

80.      Hull, J.H., Shrubbi, F.A.J.: Gentamicin serum concentrations: pharmacokinetic predictions. Ann. Intern. Med.  85: 183 (1976)